High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Tetraspanin CD37 is predominantly expressed on the cell surface of mature B lymphocytes and is currently being studied as novel therapeutic target for B-cell lymphoma. Recently, we demonstrated that loss of CD37 induces spontaneous B-cell lymphoma in Cd37-knockout mice and correlates with inferior s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood
Glavni autori: Elfrink, Suraya, de Winde, Charlotte M., van den Brand, Michiel, Berendsen, Madeleine, Roemer, Margaretha G. M., Arnold, Frank, Janssen, Luuk, van der Schaaf, Alie, Jansen, Erik, Groenen, Patricia J. T. A., Eijkelenboom, Astrid, Stevens, Wendy, Hess, Corine J., van Krieken, J. Han, Vermaat, Joost S. P., Cleven, Arjen H. G., de Groen, Ruben A. L., Neviani, Viviana, de Jong, Daphne, van Deventer, Sjoerd, Scheijen, Blanca, van Spriel, Annemiek B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2019
Teme:
Lymphoid Neoplasia
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6789512/
https://ncbi.nlm.nih.gov/pubmed/31366619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019001185
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items